A 62-year-old male presented with generalized weakness and abdominal discomfort since the past 4 months; there were no other significant complaints. On examination, the patient was pale and his abdominal palpitation revealed an enlarged, firm, nontender splenomegaly 10-cm below the costal margin. His complete blood count results were as follows: white blood cell (WBC) count, 3.0 × 10 9
/L; red blood cell count, 2.37 × 10 12 /L; hemoglobin, 6.7 g/dl; and platelet count, 30 × 10 9 /L. A peripheral blood smear demonstrated normocytic normochromic red cells with a WBC differential count of 22% polymorphs, 70% lymphocytes, 2% monocytes, 1% eosinophils and 5% atypical cells [ Figure 1a and b]. Bone marrow aspiration was not possible ("dry tap"). The hematoxylin and eosin staining of the trephine bone marrow biopsy showed an infiltration by cells with a characteristic "fried egg" appearance of the cytoplasm [ Figure 2 ]. www.sjmms.net
DOI:
10.4103/sjmms.sjmms_234_18 Immunophenotyping and immunohistochemistry analysis are critical in establishing this diagnosis.
DISCUSSION
HCL is an uncommon chronic lymphoid leukemia that constitutes approximately 2% of all adult leukemias. [1] HCL affects males more commonly than females (male: female ratio = 4:1) and the median age at diagnosis is 50-59 years. [2] In general, HCL patients present with splenomegaly (>3 cm below the costal margin) and pancytopenia without lymphadenopathy and with the associated fatigue, abdominal pain in the left upper quadrant, fever and/or infections. [1, 2] Identification of the hairy cells can be made by careful examination of the peripheral blood smears and assessment of the complete blood count, as monocytopenia is characteristically observed. [1, 2] Hairy cells are lymphoid cells having an oval or bean-shaped nucleus with loose chromatin and abundant pale blue cytoplasm with circumferential hair-like projections. [2, 3] The characteristic immunophenotypic profile includes positive expression of CD19, CD20, CD22 and CD200 antibodies as well as positivity for at least three of the following antibodies: CD11c, CD25, CD103 and CD123. In contrast, for CD5, CD10, CD23, CD27 and CD79b antibodies, hairy cells are negative or dim. [1, 3] A bone marrow examination is necessary to understand the extent of infiltration as well as to assess response to treatment; however, bone marrow aspiration is extremely difficult to obtain, as it is usually a "dry tap." [3] Nonetheless, a bone marrow trephine biopsy would help determine the degree of infiltration and the presence of BRAF V600E somatic mutation, which is present in about 90% of HCL cases. Immunohistochemical stains using CD20, CD76, annexin A1 and tartrate-resistant acid phosphatase stain would support HCL diagnosis and highlight the extent of lymphoid infiltrates. [1, 3] The differential diagnosis of HCL includes the HCL variant, splenic marginal zone lymphoma, chronic lymphocytic leukemia, prolymphocytic leukemia and mantle cell lymphoma. [1] However, with the support of immunophenotyping and immunohistochemistry, HCL diagnosis can be established.
Over the decades, HCL treatment modality has changed from splenectomy to recombinant interferon-alpha to adenosine deaminase inhibitor deoxycoformycin (pentostatin). However, purine analogs are the mainstay of HCL therapy, of which 2-chlorodeoxyadenosine (cladribine) is the most active with very high response rates. [3, 4] Financial support and sponsorship
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